Literature DB >> 23485790

Treatment of colorectal anastomotic leakage: results of a questionnaire amongst members of the Dutch Society of Gastrointestinal Surgery.

F Daams1, J C Slieker, A Tedja, T M Karsten, J F Lange.   

Abstract

Anastomotic leakage after colorectal surgery is correlated with considerable morbidity and mortality. Although many studies focus on risk factors and detection, studies on the treatment strategy for colorectal anastomotic leakage are scarce. A national questionnaire amongst 350 members of the Dutch Society for Gastrointestinal Surgery was undertaken on the current treatment of colorectal anastomotic leakage. The response was 40% after two anonymous rounds. 27% of the respondents state that a leaking anastomosis above the level of the promontory should be salvaged in ASA 1-2 patients <80 years of age, for ASA 3 and/or >80 years of age this percentage is 7.3%. For an anastomosis under the promontory, 50% of the respondents choose preserving the anastomosis for ASA 1-2 compared to 17% for ASA 3 and/or >80 years of age. In ASA 1-2 patients with a local abscess after a rectum resection without protective ileostomy, 31% of the respondents will create an protective ileostomy, 40% break down the anastomosis to create a definite colostomy, in ASA 3 and/or >80 years of age 14% of the respondents create a protective ileostomy and 63% a definitive colostomy. In ASA 1-2 patients with peritonitis after a rectum resection with deviating ileostomy, 31% prefer a laparotomy for lavage and repair of the anastomosis, 25% for lavage without repair and 36% of the respondents prefer to break down the anastomosis. When the patient is ASA 3 and/or >80 years of age, 13% prefer repair, 9% a lavage and 74% breaking down the anastomosis. This questionnaire shows that in contrast to older people, more surgeons make an effort to preserve the anastomosis in younger people.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23485790     DOI: 10.1159/000346348

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  Management of postoperative gastrointestinal leakage with autologous stromal vascular fraction.

Authors:  Saleh M Aldaqal; Meiaad F Khayat; Rana Y Bokhary; Mazen M Wakka; Adnan A Merdad; Leena A Merdad
Journal:  Int Surg       Date:  2015-04

2.  Colorectal anastomotic leakage: aspects of prevention, detection and treatment.

Authors:  Freek Daams; Misha Luyer; Johan F Lange
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

3.  Anastomotic leakage after laparoscopic single-port sigmoid resection: combined transanal and transabdominal minimal invasive management.

Authors:  Walter Brunner; Andrea Rossetti; Larissa Clea Vines; Nabil Kalak; Stephan Andreas Bischofberger
Journal:  Surg Endosc       Date:  2015-03-18       Impact factor: 4.584

4.  Use of transanastomotic double-pigtail stents in the management of grade B colorectal leakage: a pilot feasibility study.

Authors:  Christelle Blot; Charles Sabbagh; Lionel Rebibo; Franck Brazier; Cyril Chivot; Mathurin Fumery; Jean-Marc Regimbeau
Journal:  Surg Endosc       Date:  2015-07-17       Impact factor: 4.584

Review 5.  Integrated approach to colorectal anastomotic leakage: Communication, infection and healing disturbances.

Authors:  Cloë L Sparreboom; Zhou-Qiao Wu; Jia-Fu Ji; Johan F Lange
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

6.  Management of colorectal anastomotic leakage using endoscopic negative pressure therapy with or without protective ostomy: a retrospective study.

Authors:  Flavius Şandra-Petrescu; Emmanouil Tzatzarakis; Georg Kähler; Christoph Reissfelder; Florian Herrle
Journal:  Int J Colorectal Dis       Date:  2021-08-28       Impact factor: 2.571

7.  Validation of a modified clinical risk score to predict cancer-specific survival for stage II colon cancer.

Authors:  Raymond Oliphant; Paul G Horgan; David S Morrison; Donald C McMillan
Journal:  Cancer Med       Date:  2014-12-08       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.